Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3426 | 1132 | 21.1 | 37% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
529 | 17068 | BACULOVIRUS//NUCLEOPOLYHEDROVIRUS//ACMNPV |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
25040 | 245 | OMSK VET//AMIXIN//CAS 75706 12 6 |
27849 | 180 | BENFLURON//9 HYDROXYBENFLURON//BENZOCFLUORENE DERIVATIVES |
28054 | 176 | LOBAPLATIN//AFFILIATED JIANGSU CANC HOSP//PHY906 |
29768 | 147 | POLYMETHYL VINYL ETHER MALEIC ANHYDRATE//POLYMETHYL VINYL ETHER MALEIC ANHYDRIDE//ANIONIC POLYMER |
30515 | 136 | |
31821 | 117 | CALCIUM TITANIUM PHOSPHATE//PRONECTIN F//HUMAN EMBRYONIC LUNG CELL |
34540 | 68 | 2 3 4 DIARYL 5 OXO 1 2 4 TRIAZINE 6 YLIDENEACETATES//3 4 DIARYL 1 2 4 TRIAZOLO 5 CARBOXYLATES//ADEUOVIRUS |
34747 | 63 | C18L GENE//GO GENE ONTOLOGY//KEGG KYOTO ENCYCLOPEDIA OF GENES AND GENOMES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LOBAPLATIN | Author keyword | 25 | 70% | 2% | 21 |
2 | AFFILIATED JIANGSU CANC HOSP | Address | 20 | 46% | 3% | 32 |
3 | PHY906 | Author keyword | 9 | 83% | 0% | 5 |
4 | BENFLURON | Author keyword | 2 | 67% | 0% | 2 |
5 | KANGLAITE INJECTION | Author keyword | 2 | 67% | 0% | 2 |
6 | POLYMETHYL VINYL ETHER MALEIC ANHYDRATE | Author keyword | 2 | 67% | 0% | 2 |
7 | CALCIUM TITANIUM PHOSPHATE | Author keyword | 2 | 43% | 0% | 3 |
8 | 9 HYDROXYBENFLURON | Author keyword | 1 | 100% | 0% | 2 |
9 | BENZOCFLUORENE DERIVATIVES | Author keyword | 1 | 100% | 0% | 2 |
10 | CANTHARIDES SODIUM INJECTION | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MATERIAL TAM | 73 | 96% | 2% | 23 |
2 | 9 HYDROXYBENFLURON | 23 | 100% | 1% | 10 |
3 | D 19466 | 13 | 71% | 1% | 10 |
4 | TREATING PATIENTS | 10 | 44% | 2% | 17 |
5 | POSTOPERATIVE ADJUVANT CHEMOTHERAPY | 9 | 21% | 4% | 40 |
6 | POTENCY ASSAY | 4 | 75% | 0% | 3 |
7 | EHRLICH ASCITES | 4 | 56% | 0% | 5 |
8 | SUBSTRATE DEPENDENT DIFFERENCES | 2 | 67% | 0% | 2 |
9 | MALEIC ANHYDRIDE COATED BEADS | 2 | 50% | 0% | 3 |
10 | ACTIVE IMMUNE RESPONSIVENESS | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Traditional Chinese Medicine in Cancer Care: A Review of Case Series Published in the Chinese Literature | 2012 | 8 | 1 | 100% |
Old formula, new Rx: The journey of PHY906 as cancer adjuvant therapy | 2012 | 22 | 26 | 19% |
Russian experience in screening, analysis, and clinical application of novel interferon inducers | 2001 | 9 | 17 | 76% |
Viral Safety of Biologicals: Evaluation of Hepatitis C Virus (HCV) Nucleic Acid Amplification Test (NAT) Assay and Development of Concentration Method of HCV for Sensitive Detection by NAT | 2010 | 0 | 1 | 100% |
ALPHA-TRIGLYCIDYL-URAZOL BETA-TRIGLYCIDYL-URAZOL (TGU, NSC 332488, INN - ANAXIRONE) - A NEW CHEMOTHERAPEUTIC AGENT | 1984 | 9 | 4 | 75% |
GENETIC-ENGINEERING IN DESIGNING MEDICATIONS - PROGRESS AND PROSPECTS | 1993 | 2 | 3 | 67% |
Traditional Herbal Medicine: A Review of Potential of Inhibitory Hepatocellular Carcinoma in Basic Research and Clinical Trial | 2013 | 3 | 28 | 21% |
INTERFERON-PRODUCTION IN MICROCARRIER CULTURE OF HUMAN FIBROBLAST CELLS | 1984 | 4 | 2 | 100% |
COMPLEX SYSTEM OF THE NONSPECIFIC PROPHYLAXIS OF INFLUENZA AND ACUTE RESPIRATORY-DISEASES - POTENTIALITIES AND PROSPECTS | 1990 | 0 | 1 | 100% |
IMMUNOGLOBULINS IN VIROLOGICAL STUDIES AND IN PREVENTION OF SOME INFECTIONS | 1992 | 0 | 6 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AFFILIATED JIANGSU CANC HOSP | 20 | 46% | 2.8% | 32 |
2 | OMSK VET | 1 | 100% | 0.2% | 2 |
3 | EXPT BIOPHARMACEUT | 1 | 14% | 0.7% | 8 |
4 | MOLEC PHYSIOL GENET | 1 | 33% | 0.2% | 2 |
5 | WOMEN HLTH CARE | 1 | 33% | 0.2% | 2 |
6 | COMPLEMENTARY MED COMPLEMED | 1 | 50% | 0.1% | 1 |
7 | CONTROLLED RELEASE DRUG | 1 | 50% | 0.1% | 1 |
8 | DEV THER EUT PROGRAMYALE CANC | 1 | 50% | 0.1% | 1 |
9 | HONG KONG COCHRANE | 1 | 50% | 0.1% | 1 |
10 | MINIST PUBL HLTH LIVING DONOR LIVER TRANS | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000011259 | IMEXON//LEVAMISOLE//TYROSERLEUTIDE |
2 | 0.0000007879 | BIOTECHNOLOGY AND BIOENGINEERING//MAMMALIAN CELL CULTURE//HYBRIDOMA |
3 | 0.0000007490 | JOURNAL OF INTERFERON RESEARCH//ISG15//JOURNAL OF INTERFERON AND CYTOKINE RESEARCH |
4 | 0.0000005809 | COMMON COLD THERAPY//FUNDAMENTALS OF CARE//DAMAGE TO ELEVATORS |
5 | 0.0000005532 | RABIES//RABIES VIRUS//LYSSAVIRUS |
6 | 0.0000005132 | CISPLATIN//NAMI A//NEPHROTOXICITY |
7 | 0.0000004654 | WEST NILE VIRUS//FLAVIVIRUS//DENGUE VIRUS |
8 | 0.0000004573 | VESTNIK DERMATOLOGII I VENEROLOGII//BRCN ACTIVATED SEPHAROSE//CURANTIL |
9 | 0.0000004037 | BORNA DISEASE VIRUS//AVIAN BORNAVIRUS//PROVENTRICULAR DILATATION DISEASE |
10 | 0.0000003951 | CHROMIUM SOAPS//METAL ALKANOATE//V VERNADSKI GEN INORGAN CHEM |